Carcinoid syndrome with myasthenia gravis. An unusual and interesting case.
The anaesthetic management of a patient suffering from carcinoid syndrome and myasthenia gravis is described including the successful treatment of a carcinoid attack with intravenous aprotonin. The differences between myasthenia gravis and the myasthenic (Eaton-Lambert) syndrome are considered and the rationale for the choice of vecuronium as the muscle relaxant is discussed.
Keens
S J
SJ
Desmond
M J
MJ
Utting
J E
JE
D000200:Action Potentials / Q000187:drug effects; D000368:Aged; D000768:Anesthesia, General; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000150:complications* / Q000601:surgery; D009157:Myasthenia Gravis / Q000150:complications*; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology; D010197:Pancuronium / Q000031:analogs & derivatives / Q000494:pharmacology; D014673:Vecuronium Bromide
D009466:Neuromuscular Blocking Agents; D014673:Vecuronium Bromide; D010197:Pancuronium